default author photo

Yufan Tan

Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation

195 Dongfeng W Rd

Yuexiu Qu

Guangzhou Shi, Guangdong Sheng 510080

China

SCHOLARLY PAPERS

2

DOWNLOADS

153

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life

Number of pages: 37 Posted: 10 Jul 2019
Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, University of South Dakota, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation and Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation
Downloads 102 (679,608)

Abstract:

Loading...

Alzheimer's disease; Bilirubin; Spatial learning and memory injury; tau protein; Tau hyperphosphorylation; protein kinase; APP; βamyloid; γ-secretase; α-secretase

2.

Bilirubin Restrains the Anticancer Effects of Vemurafenib on BRAF-Mutant Melanoma Cells via ERK-MNK1 Signaling

Number of pages: 27 Posted: 07 Apr 2021
Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, University of Texas at Dallas - Southwestern Medical Center, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Guangzhou Medical University - Affiliated Cancer Hospital & Institute and Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation
Downloads 51 (1,052,702)

Abstract:

Loading...

bilirubin, vemurafenib, ERK, MNK1, BRAF-mutant melanoma